Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial
No Thumbnail Available
Issue Date
2025
Our author(s)
Walker, Z.
Department
Keywords
Dementia , Clinical trials , Neurology
Language
en
Publisher
Nature Portfolio
ISSN
1078-8956
eISSN
1546-170X
ISBN
Type
article
Citation
Edison, P., Femminella, G.D., Ritchie, C., Nowell, J., Holmes, C., Walker, Z., Ridha, B., Raza, S., Livingstong, N.R., Frangou, E., Love, S., Williams, G., Lawrence, R., Mcfarlane, B., Archer, H., Coulthard, E., Underwood, B.R., Koranteng, P., Karim, S., Bannister, C., Perneczky, R., Prasanna, A., Junaid, K., McGuinness, B., Nilorooshan, R., Macharouthu, A., Donaldson, A., Thacker, S., Russell, G., Malik, N., Mate, V., Knight, L., Kshemendran, S., Holscher, C., Mansourit, A., Chester-Jones, M., Holmes, J., Tan, T., Williams, S., Ashraf, A., Brooks, D.J., Harrison, J., Hinz, R., Tadros, G., Passmore, A.P. & Ballard, C. 2025. Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial. Nature Medicine, December 1, (Online ahead of print).